Working with Policy Customers

Research funded by the NIHR HTA programme directly influences key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE). NICE is responsible, through technology appraisals, for providing national guidance on new and existing medicines and treatments within England and Wales.

The NIHR HTA programme commissions independent Health Technology Assessment reviews to support NICE committees deliver national guidance on new and existing treatments or interventions, and on medical diagnostic technologies to the NHS in England and Wales, through its Technology Appraisals and Diagnostic Assessments respectively.

View How the HTA programme works with policy customers leaflet (pdf, 2,304kb)

The HTA programme also regularly commissions the specialist centres to use their skills to prepare reports for other policy customers. These reports are tailored in size specifically to support policy customer’s needs for their decision making process. HTA Assessment Reports (HTA TARs) usually comprise a systematic review of the evidence for an intervention in a specific healthcare area and often a specially designed economic model used to independently assess the cost-effectiveness of the intervention options, plus any other necessary components.

View how HTA work with NICE page

Advanced search How to use the search function